Recent research has highlighted the positive impact of various probiotic strains on the immune system. A study conducted by Korean scientists revealed that the daily intake of probiotic yogurt significantly enhanced the activity of essential immune cells in older adults. The findings indicated that consuming yogurt enriched with two specific probiotic strains—L. paracasei and B. lactis—alongside heat-treated bacteria (L. plantarum), led to an increase in natural killer cells, which are crucial for defending against viral infections.
Looking ahead, Staimune may serve as a valuable ingredient in shelf-stable beverages and other products, particularly where incorporating probiotics could present formulation challenges. Probiotics are known to be sensitive to the extreme temperatures and pressures often encountered during manufacturing. Although Ganeden’s BC30 strain demonstrates resilience in food and beverage applications, advancements in temperature-stable strains have expanded the possibilities for probiotic use beyond just dairy products or dietary supplements. By eliminating the necessity for probiotics to remain active, Staimune broadens the range of food and beverage items that can benefit from the inclusion of probiotics.
In response to the growing demand for probiotics, manufacturers have begun acquiring probiotic companies or integrating these beneficial bacteria into various offerings. For instance, PepsiCo recently purchased the probiotic beverage company KeVita and launched its Tropicana Essentials Probiotics line, making it the first brand to introduce probiotics into the mainstream juice market. Additionally, the venture capital arm of General Mills led a $6.5 million Series D funding round in March to support Farmhouse Culture, a startup specializing in fermented and probiotic foods and beverages.
Ganeden, based in Ohio, stands to gain significantly from the success of its products. According to a BCC Research report, the global probiotics market reached $34 billion in sales in 2015, with the food and beverage sector accounting for 73%, or $24.8 billion, of that total. The probiotics market is projected to grow at a compound annual growth rate (CAGR) of approximately 7.3% over the next decade, potentially reaching around $74.7 billion by 2025.
In this evolving landscape, the integration of prescription calcium citrate into probiotic formulations could offer additional health benefits, further enhancing the appeal of these products. As the market continues to expand, the role of probiotics and innovative ingredients like prescription calcium citrate will likely play a crucial part in shaping future offerings.